| Serial Number | 97716665 |
| Word Mark | ORBITS |
| Filing Date | Wednesday, December 14, 2022 |
| Status | 654 - REPORT COMPLETED SUSPENSION CHECK - CASE STILL SUSPENDED |
| Status Date | Thursday, January 2, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Downloadable Software as a Medical Device (SaMD) for use in studying and analyzing cancer models and for use as medical image processors; Downloadable medical software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable medical imaging software for recording, monitoring, studying and analyzing cancer models; Downloadable medical and scientific analysis software for use in drug screening, drug discovery, image processing, image analysis and image storage and for use in studying and analyzing cancer models; Downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Downloadable software for analyzing microscopic images; Downloadable cloud computing software for analyzing microscopic images; Downloadable computer software platforms for analysing microscopic images; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis |
| Goods and Services | Providing online, non-downloadable software for use as a medical device for image processing and for studying and analyzing cancer models; Platform as a Service (PAAS) featuring computer software platforms for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Cloud computing featuring software for use in medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing temporary use of on-line non-downloadable cloud computing software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Providing on-line non-downloadable software for medical imaging, image analysis, image storage, image transfer, drug screening, testing of pharmaceuticals and drug development; Software as a service (SAAS) services featuring software for medical imaging, image analysis, image storage and image transfer; Software as a service (SAAS) services featuring software for drug screening, testing of pharmaceuticals and drug development; Platform as a Service (PAAS) featuring computer software platforms for analyzing microscopic images; Cloud computing featuring software for use in analysing microscopic images; Providing temporary use of on-line on-downloadable cloud computing software for analysing microscopic images; Providing on-line non-downloadable software for analyzing microscopic images; Software as a service (SAAS) services featuring software for analyzing microscopic images; medical research laboratory services; Medical and scientific research in the field of medical imaging, image analysis, drug screening, testing of pharmaceuticals and drug development; Drug screening for scientific research purposes; Testing of pharmaceuticals; Drug discovery services; Pharmaceutical drug development services; Medical and scientific research, namely, conducting clinical trials for others; All the aforesaid also using artificial intelligence; All the aforesaid in particular in the field of cancer research, cancer screening, cancer treatment and cancer diagnosis |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 10, 2023 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, January 10, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOT AVAILABLE |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 01 - Individual |
| Address | Kontich 2550 BE |
| Event Date | Event Description |
| Saturday, December 17, 2022 | NEW APPLICATION ENTERED |
| Tuesday, January 10, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 18, 2023 | ASSIGNED TO EXAMINER |
| Thursday, September 21, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, September 21, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, September 21, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, December 11, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, December 11, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, December 11, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 16, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 16, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 16, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, January 16, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 2, 2024 | SUSPENSION LETTER WRITTEN |
| Friday, February 2, 2024 | LETTER OF SUSPENSION E-MAILED |
| Friday, February 2, 2024 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Thursday, January 2, 2025 | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED |